Gender Completed Phase 4 Trials for Emtricitabine (DB00879)

IndicationStatusPhase
DBCOND0056753 (Gender)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01571128Gender-Specific Combination HIV Prevention for Youth in High Burden Settings (MP3-Youth)Prevention